Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

> 5% of Cmax for endogenous molecule? [Regulatives / Guidelines]

posted by Ramesh Ramalingam – India, 2018-06-18 10:00 (2136 d 22:04 ago) – Posting: # 18913
Views: 3,869

Dear All,

As per guidelines, Subjects with non-zero baseline concentrations > 5% of Cmax. Such data should be excluded from bioequivalence calculation.

Is it applicable for endogenous molecule? could you please suggest anyone..

Regards,
Ramesh. R

Complete thread:

> 5% of Cmax for endogenous molecule?Ramesh Ramalingam 2018-06-18 08:00 [Regulatives / Guidelines]
- Any own thoughts? Helmut 2018-06-18 10:59
  - carryover effect in endogenous substances Ramesh Ramalingam 2018-08-08 07:29

Admin contact
22,993 posts in 4,828 threads, 1,659 registered users;
70 visitors (0 registered, 70 guests [including 5 identified bots]).
Forum time: 08:04 CEST (Europe/Vienna)

So far as I can remember,
there is not one word in the Gospels
in praise of intelligence. Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz